TB Alert

Last updated

TB Alert is a charity working to raise awareness about and support effective treatment of the disease tuberculosis in the UK and internationally. It was registered in 1998 and launched on World Tuberculosis Day in 1999 [1] in response to the resurgence of tuberculosis (TB) in the UK and worldwide. [2] It is headquartered in Brighton.

Contents

Vision, mission and approach

The stated vision of TB Alert is the control and ultimate eradication of TB. Their mission is to increase access to effective treatment for all.

The organisation works towards this by:

Active projects

UK projects

TB Action Group

The TB Action Group (TBAG) is a group of people with an interest in promoting awareness of TB in the UK, providing peer support to patients and lobbying for improvements to the existing treatment and support provided by the NHS. Although TB Alert provided funding and administrative support to the group, decisions on its specific activities are taken by its members, who are typically current or former TB patients, or have been affected by the illness of someone close to them.

Raising awareness

A key element of TB Alert's work in the UK is making medical professionals and the general public aware of the continued existence of tuberculosis in the UK. Examples of their activities in this area include:

  • providing leaflets and posters for use in doctors' waiting rooms
  • responding to requests for information from the media, patients and medical professionals
  • mounting exhibitions
  • providing speakers at medical and nursing conferences
  • producing detailed leaflets about treatment and clinical issues for use by patients and healthcare professionals

Patient support

In recognition of the fact that many TB patients come from the poorer sections of society and may find this a barrier to completing treatment, a patient support fund is available to provide small grants. The money can go towards costs such as bus fares to attend appointments or nutritious food to support recovery.

India

TB Alert India

TB Alert India is registered separately in India and partnered with TB Alert in the UK. It was founded in 2004. [3] Projects include the establishment of microscopy centres to aid diagnosis, education programmes about TB and the increased risk in conjunction with HIV infection, training DOTS providers and supporting other NGOs with established links to local communities to help raise awareness in those communities. Work is focussed on Andhra Pradesh, which projects also running in Delhi, Bihar, Uttar Pradesh and Madhya Pradesh.

Nav Jivan Mission Hospital (NJMH) is situated in Palamu District, Jharkhand. With support from TB Alert the hospital has established facilities for the free diagnosis and treatment of TB, serving mainly local subsistence farmers and their families.

Zambia

Bwafwano

TB Alert has provided support enabling Bwafwano, a Zambian charity based in Lusaka [4] to train volunteers to provide treatment, support and counselling to patients in their local community. Workshops are also run for community leaders, informing them about TB and HIV and the work that Bwafwano does.

Chichetekelo Outreach Partners

TB Alert provides funding for this project in the poor Kabwe province, where rates of TB and HIV are high and infection carries a powerful social stigma. Chichetekelo uses adults who have been cured of TB as outreach partners, visiting villages and speaking in centres such as schools or churches about their experience. They address myths and misconceptions surrounding TB and spread the message that TB is a treatable disease.

Zimbabwe

In Zimbabwe, TB Alert supports the TB services at Murambinda hospital [5] in Buhera District. The hospital is owned by the Sisters of the Little Company of Mary. Recent economic turmoil in Zimbabwe has placed enormous pressure on healthcare services, as well as leaving the population more vulnerable to tuberculosis infection through lack of proper nutrition.

President and Patrons

Honorary President

Sir John Crofton 19122009.

Emeritus Professor of Respiratory Diseases and Tuberculosis, University of Edinburgh Sir John Crofton was knighted in 1977 for his contributions to TB control. As Professor of tuberculosis and respiratory disease in Edinburgh (where TB was the leading cause of death in young people) in the 1950s, Sir John led the team responsible for bringing TB under control in only 6 years – 1/3 of the time predicted. This was the first demonstration of mass control of TB, and his no-nonsense "Edinburgh method" was subsequently instituted in 23 European countries. An indefatigable pioneer and international physician, Sir John has been a leader in the work of the World Health Organization (WHO) and other international bodies, a celebrated author and an influential teacher. The International Union Against Tuberculosis and Lung Disease (IUATLD) awarded Sir John the organisation's highest award, The Union Medal, which recognises outstanding contributions to the control of tuberculosis and lung disease, on October 19, 2005. Never one to slow down, to the end of his life, aged 97, Crofton continued as an inspiring worker in the field of tuberculosis and tobacco control, and fundraising tirelessly on behalf of TB Alert. He will be sadly missed.

Patrons

Lord (Robert) Kilpatrick of Kincraig, Doctor and past President of the General Medical Council. He was one of the first patients to be treated with streptomycin.

Archbishop Emeritus Desmond Tutu, South African activist and Nobel Peace Prize winner.

Related Research Articles

<span class="mw-page-title-main">Tuberculosis</span> Infectious disease

Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs, but it can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. Around 10% of latent infections progress to active disease which, if left untreated, kill about half of those affected. Typical symptoms of active TB are chronic cough with blood-containing mucus, fever, night sweats, and weight loss. It was historically referred to as consumption due to the weight loss associated with the disease. Infection of other organs can cause a wide range of symptoms.

<span class="mw-page-title-main">Tuberculosis diagnosis</span>

Tuberculosis is diagnosed by finding Mycobacterium tuberculosis bacteria in a clinical specimen taken from the patient. While other investigations may strongly suggest tuberculosis as the diagnosis, they cannot confirm it.

<span class="mw-page-title-main">Tuberculosis management</span>

Tuberculosis management describes the techniques and procedures utilized for treating tuberculosis (TB).

Lepra (Leprosy Relief Association) is a UK-based international charity established in 1924, working to diagnose, treat, and rehabilitate people with leprosy. Lepra currently works in India, Bangladesh and Zimbabwe.

<span class="mw-page-title-main">Partners In Health</span> Non-profit health care organization

Partners In Health (PIH) is an international nonprofit public health organization founded in 1987 by Paul Farmer, Ophelia Dahl, Thomas J. White, Todd McCormack, and Jim Yong Kim.

Medical Emergency Relief International (Merlin) is a former British international non-governmental health charity which sends medical experts to global emergencies. In July 2013, Merlin merged with Save the Children.

Latent tuberculosis (LTB), also called latent tuberculosis infection (LTBI) is when a person is infected with Mycobacterium tuberculosis, but does not have active tuberculosis (TB). Active tuberculosis can be contagious while latent tuberculosis is not, and it is therefore not possible to get TB from someone with latent tuberculosis. The main risk is that approximately 10% of these people will go on to develop active tuberculosis. This is particularly true, and there is added risk, in particular situations such as medication that suppresses the immune system or advancing age.

<span class="mw-page-title-main">Extensively drug-resistant tuberculosis</span> Tuberculosis that is resistant to the most effective drugs

Extensively drug-resistant tuberculosis (XDR-TB) is a form of tuberculosis caused by bacteria that are resistant to some of the most effective anti-TB drugs. XDR-TB strains have arisen after the mismanagement of individuals with multidrug-resistant TB (MDR-TB).

<span class="mw-page-title-main">Tuberculosis in China</span>

Tuberculosis is a serious public health problem in China. China has the world's third largest cases of tuberculosis, but progress in tuberculosis control was slow during the 1990s. Detection of tuberculosis had stagnated at around 30% of the estimated total of new cases, and multidrug-resistant tuberculosis was a major problem. These signs of inadequate tuberculosis control can be linked to a malfunctioning health system. The spread of severe acute respiratory syndrome (SARS) in 2003, brought to light substantial weaknesses in the country's public health system. After the government realized the impact that the SARS outbreak had on the country, they increased leadership in their health department. After the SARS epidemic was brought under control, the government increased its commitment and leadership to tackle public health problems and, among other efforts, increased public health funding, revised laws that concerned the control of infectious diseases, implemented the world's largest internet-based disease reporting system to improve transparency, reach and speed, and started a program to rebuild local public health facilities and national infrastructure.

<span class="mw-page-title-main">Health in Vietnam</span>

Life expectancy has risen by two years for males and females in Vietnam between 2000 and 2012. This is half of the average rise in life expectancy for other parts of the world during the same time period.

The INCTR Challenge Fund is the UK charity (Charity No. 1079181) raising funds for projects co-ordinated by the International Network for Cancer Treatment Research (INCTR) that improve the care delivered to cancer patients in developing countries and help reduce their suffering.

<span class="mw-page-title-main">Alimuddin Zumla</span> British-Zambian physician

Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2022, for the fifth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.

<span class="mw-page-title-main">Karel Styblo</span>

Karel Styblo was a Czech-Dutch physician. Internationally recognized for his work with tuberculosis (TB), he was a medical advisor to the Royal Netherlands Tuberculosis Association, and was named director of the International Union Against Tuberculosis and Lung Disease (IUATLD) in 1979. He is known as the "father of modern TB epidemiology" and the "father of modern TB control".

Sir John Wenman Crofton was a pioneer in the treatment of tuberculosis, who also spent the better part of his life raising awareness about the harmful effects of tobacco.

<span class="mw-page-title-main">Tuberculosis in India</span> Health issue in India

Tuberculosis in India is a major health problem, causing about 220,000 deaths every year. In 2020, the Indian government made statements to eliminate tuberculosis from the country by 2025 through its National TB Elimination Program. Interventions in this program include major investment in health care, providing supplemental nutrition credit through the Nikshay Poshan Yojana, organizing a national epidemiological survey for tuberculosis, and organizing a national campaign to tie together the Indian government and private health infrastructure for the goal of eliminating the disease.

Government Hospital of Thoracic Medicine, popularly known as the Tambaram TB Sanatorium, is a major state-owned hospital situated in Chennai, India. The hospital is funded and managed by the state government of Tamil Nadu. It was founded in 1928.

<span class="mw-page-title-main">Frederick Miller (paediatrician)</span> British paediatrician

Frederick John William Miller was a British paediatrician, who made critically important contributions in describing tuberculosis in childhood, including the definition of the treatment and control, of the disease. Along with Sir James Spence and Sir Donald Court, Fred Miller were responsible for the formulation of the major epidemiological cohort study called the Newcastle Thousand Families Study. After that the group was called the Newcastle Trio in the medical community.

American International Health Alliance (AIHA) is a nonprofit organisation aiming for assisting the global health. The organisation has managed more than 175 partnerships and project across the globe. In 2012, AIHA obtained the support of President's Emergency Plan for AIDS Relief [PEPFAR] project to strengthen the blood service in Central Asia, Ukraine, and Cambodia. Due to its structure based on the programmatic modal and dynamic condition, this organisation is suitable to assist the community or worldwide countries which have limited resources, and it is beneficial for sustainable evolution. AIHA is contributing to improve the worldwide health conditions. This organisation has been associated and largely contributed in the HIV-related area since 2000.

<span class="mw-page-title-main">Henry Mwandumba</span> African professor of medicine

Henry Charles Mwandumba is an African Professor of Medicine and the Director of the Malawi-Liverpool-Wellcome Programme. He works on the tuberculosis phagosome in the University of Malawi College of Medicine, and serves as President of the Federation of African Immunological Societies. In 2019 Mwandumba was awarded the Royal Society Africa Prize.

<span class="mw-page-title-main">Edinburgh City Hospital</span> Hospital in Edinburgh, Scotland

The Edinburgh City Hospital was a hospital in Colinton, Edinburgh, opened in 1903 for the treatment of infectious diseases. As the pattern of infectious disease changed, the need for in-patients facilities to treat them diminished. While still remaining the regional centre for infectious disease, in the latter half of the 20th century the hospital facilities diversified with specialist units established for respiratory disease, ear, nose and throat surgery, maxillo-facial surgery, care of the elderly and latterly HIV/AIDS. The hospital closed in 1999 and was redeveloped as residential housing, known as Greenbank Village.

References